CrossrefInfokarte
High sensitivity‑C‑reactive protein variability and risk of cancer incidence: A longitudinal prospective cohort study cancer
Experimental and Therapeutic Medicine · 2026-10-26 · 32 (6) · 1-12
DOI: 10.3892/etm.2026.13344 ↗Abstract
Kein Abstract verfügbar.
EUVIMED